Rocket


Overview
Financials
News + Filings

 
 

Lexeo Therapeutics, Inc. Add to portfolio


Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-22Dec-31-21
Revenues0.71.7
            Revenue growth-60.5% 
Cost of goods sold61.252.3
Gross profit-60.5-50.6
            Gross margin-9252.1%-3055.9%
General and administrative12.07.2
EBIT-60.5-50.6
            EBIT margin-9252.1%-3055.9%
Pre-tax income-59.3-50.6
Income taxes0.00.0
            Tax rate0.0%0.0%
Net income0.00.0
            Net margin0.0%0.0%
 
Diluted EPS$0.00$0.00
Shares outstanding (diluted)17,272.416,449.8
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy